| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Pediatric vaccine product containing only diptheria standard dose + pertussis standard dose + tetanus + hepatitis B + Haemophilus influenzae type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| TETRAMUNE suspension for injection Wyeth-Ayerst Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| DTaP-Hib ACTacel SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| TETRAMUNE suspension for injection Wyeth-Ayerst Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf INFLUVAC BGP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Inf INFLUVAC BGP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| HA EPAXAL BB |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf AGRIFLU SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Inf AGRIFLU SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf AGRIFLU SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf INFLUVAC BGP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DTaP-Hib ACTacel SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DTwP-HB Tritanrix GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DTwP-HB Tritanrix GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf AFLURIA TETRA SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| AVAXIM 160 units per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFANRIX hexa suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
8 |
| INFANRIX hexa suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Pediatric vaccine product containing whole cell pertussis standard dose antigen (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DTwP-HB diptheria + tetanus + whole cell pertussis + hepatitis B pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| HAHB Hepatitis A + B regular strength unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DTwP-HB diptheria + tetanus + whole cell pertussis + hepatitis B pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Adult vaccine product containing only Hepatitis B virus regular strength antigen (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DPT-Hib suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DPT-Hib suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| DTaP-Hib diphtheria + tetanus + acellular pertussis + Haemophilus influenzae type b pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| DTaP-Hib diphtheria + tetanus + acellular pertussis + Haemophilus influenzae type b pediatric unspecified |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| RECOMBIVAX HB 10 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFANRIX-IPV suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
5 |
| INFANRIX-IPV suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Pediatric vaccine product containing acellular pertussis antigen in standard dose (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Epaxal Berna 500 radioimmunoassay units per 0.5 milliliter suspension for injection Swiss Serum and Vaccine Institute Berne (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| DPTPH DPT-Polio-Hib AP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| DPTPH DPT-Polio-Hib AP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DCaT-VPI-Hib PENTACEL SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| DCaT-VPI-Hib PENTACEL SP |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing only diphtheria standard dose + tetanus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| DTaP-IPV KINRIX GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DTaP-IPV KINRIX GSK |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
5 |
| Inf FLUAD SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf FLUAD SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Inf FLUAD SEQ |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFANRIX-IPV/Hib suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFANRIX-IPV/Hib suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus + Haemophilus influenza type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + human poliovirus + Haemophilus influenza type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Tripacel Hybrid suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Engerix B 20 micrograms per milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Tripacel Hybrid suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| PEDIACEL suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + hepatitis b + inactivated human poliovirus + Haemophilus influenzae type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
6 |
| Pediatric vaccine product containing only diphtheria standard dose + tetanus + acellular pertussis standard dose + inactivated human poliovirus + Haemophilus influenzae type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing diphtheria standard dose + pertussis standard dose + tetanus antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| PEDIACEL suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |